Trade Mark Journal No.2026/039 25 September 2026

UK00004444122 11 September 2026 (42)

REFACTOR THERAPEUTICS

International priority date claimed: 20 March 2026 (United States of America) (99714682)

Class 42: Gene therapy research; Testing, inspection, research, or development of pharmaceutical preparations for gene therapy; Development of pharmaceuticals for cell and gene therapies.

Refactor Therapeutics, Inc.

Representative: Reddie & Grose LLP